Invigorating human MSCs for transplantation therapy via Nrf2/DKK1 co-stimulation in a mice acute-on-chronic liver failure model

Feng Chen(Sun Yat-sen University), Jia Xiao(First Affiliated Hospital of Jinan University)

bioRxiv (Cold Spring Harbor Laboratory)

May 30, 2022

10.1101/2022.05.29.493908

Cited by 0

Related Papers

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

|Journal of Clinical Oncology|2021|404

Comprehensive estimation for the length and dispersion of COVID-19 incubation period: a systematic review and meta-analysis

|Infection|2021|16

Invigorating human MSCs for transplantation therapy via Nrf2/DKK1 co-stimulation in an acute-on-chronic liver failure mouse model

|Gastroenterology report|2023|3